Ocugen

Ocugen FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Ocugen (OCGN) as of Oct 20, 2026 is 84.23 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 84.23 % — a change of 0.01% (higher).

FCF Conversion

84.23 %

YoY

0.01%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Ocugen is 2025 84.23 % . FCF Conversion Rate (FCF/EBITDA) of Ocugen was 2024 84.23 % . It decreases by 0.01% higher compared to the previous year.

The Ocugen FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
205.83 USD
Jan 1, 2019
83.60 USD
Jan 1, 2020
68.81 USD
Jan 1, 2021
83.75 USD
Jan 1, 2022
82.91 USD
Jan 1, 2023
114.98 USD
Jan 1, 2024
84.23 USD
Jan 1, 2025
84.23 USD
The Ocugen FCF Conversion history
YEARFCF ConversionYoY
84.23 %+0.01%
84.23 %-26.75%
114.98 %+38.68%
82.91 %-1.00%
83.75 %+21.71%
68.81 %-17.69%
83.60 %-59.39%
205.83 %+133.38%
88.20 %-45.14%
160.76 %+60.97%
99.87 %+4.78%
95.32 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ocugen Stock analysis

What does Ocugen do? Ocugen Inc is a US-based biopharmaceutical company specializing in the development and commercialization of innovative therapeutics and vaccines. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania. It has a strong pipeline of products in various stages of development, with a focus on treating eye diseases and other medical conditions. Ocugen has also entered into partnerships for the development and marketing of COVID-19 vaccines, including Covaxin. Overall, Ocugen Inc is expected to be a significant player in the biopharmaceutical industry in the coming years. Ocugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ocugen stock

FCF Conversion Rate (FCF/EBITDA) of Ocugen is 84.23 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Ocugen changed from 84.23 % to 84.23 %, representing a 0.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Ocugen since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Ocugen with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ocugen

All Key Metrics — Ocugen